The global intraosseous infusion devices market is increasing steadily by the years

Intraosseous infusion is a method of introducing drugs or liquids into the human bone marrow to provide a systemic entry site. When intravenous access is unavailable or impossible, this approach is frequently used. In adults and children, this method is also used for vascular access and drug administration. Infusions are usually given from the proximal and distal tibia, sternum (FAST1), and humerus EZ-IO.


The global intraosseous infusion devices market is steadily increasing, owing to an increase in the number of emergency medical cases as well as an increase in the incidence of chronic disorders such as traumatic injuries, cardiovascular diseases, obesity, and severe burns, all of which increase the likelihood of hospitalisation.

Sedentary lifestyles also have a significant impact on human health, increasing the likelihood of conditions like chronic obstructive pulmonary disease, end-stage renal disease, cardiovascular disease, diabetes, urological disorders, and other chronic illnesses. The market's growth is aided by the high success rate of about 97 percent achieved with intraosseous implants.. However, an increased risk of compartment syndrome due to the spilling of fluids and medications into soft tissues, as well as restrictions on use in those with severe osteoporosis and hypovolemic situations, could limit market growth.

The global intraosseous infusion device market is divided into four categories: product type, technology, administration route, end user, and geography.. The market is divided into FAST1 device, Dieckmann modified needle, BIG device, EZ-IO device, Jamshidi needle, FASTx device, and NIO based on product type. The market is divided into three categories based on technology: battery-powered drivers, manual IO needles, and impact-driven devices.Based on the manner of administration, the market is classified into four segments: distal femur, sternum, distal & proximal tibia, and calcaneus, and head of humerus. The market is segmented into hospitals, emergency medical ambulatory surgical centres, services, and cardiac care centres based on end-users. The market has been studied across North America, Europe, Asia-Pacific, and LAMEA.

This study also includes a detailed competitive analysis and profiles of leading market players such as Pyng Medical Corp., Biopsybell, Cook Medical Incorporated, PAVmed, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Becton Dickinson and Company.

Comments

Popular posts from this blog

YOU YES YOU!

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

From 2016-2021, Automated Fare Collection System Market predicted to rise significantly